These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15715820)

  • 1. Movement disorders and the treatment of schizophrenia.
    Ellard J
    Australas Psychiatry; 2004 Dec; 12(4):409. PubMed ID: 15715820
    [No Abstract]   [Full Text] [Related]  

  • 2. Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report.
    Mall GD; Hake L; Benjamin AB; Adityanjee A
    J Clin Psychopharmacol; 2008 Oct; 28(5):572-3. PubMed ID: 18794658
    [No Abstract]   [Full Text] [Related]  

  • 3. The emerging role of atypical antipsychotics in the treatment of tardive dyskinesia induced by other atypical antipsychotics.
    Peritogiannis V; Tsouli S
    J Clin Psychiatry; 2011 Jul; 72(7):1016; author reply 1016-7. PubMed ID: 21824463
    [No Abstract]   [Full Text] [Related]  

  • 4. [Olanzapine-associated neuroleptic malignant syndrome. A case report and favorable response to risperidone].
    López-Torres E; Cobo I; Lucena MI
    Actas Esp Psiquiatr; 2007; 35(2):145-6. PubMed ID: 17401786
    [No Abstract]   [Full Text] [Related]  

  • 5. Poorly controlled EPS: risk factors for NMS.
    Primeau F; Fontaine R; Chouinard G
    Can J Psychiatry; 1987 May; 32(4):328, 331. PubMed ID: 2886211
    [No Abstract]   [Full Text] [Related]  

  • 6. Risperidone-induced tardive dyskinesia.
    Hong KS; Cheong SS; Woo JM; Kim E
    Am J Psychiatry; 1999 Aug; 156(8):1290. PubMed ID: 10450277
    [No Abstract]   [Full Text] [Related]  

  • 7. Caution is still needed when prescribing atypical antipsychotics.
    Carey S
    Br J Hosp Med (Lond); 2008 May; 69(5):299. PubMed ID: 18557562
    [No Abstract]   [Full Text] [Related]  

  • 8. Clozapine withdrawal catatonia, psychosis and associated neuroleptic malignant syndrome.
    Ingole A; Bastiampillai T; Tibrewal P
    Asian J Psychiatr; 2017 Dec; 30():96-97. PubMed ID: 28846884
    [No Abstract]   [Full Text] [Related]  

  • 9. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.
    Paparrigopoulos T; Tzavellas E; Ferentinos P; Mourikis I; Liappas J
    World J Biol Psychiatry; 2009; 10(1):70-3. PubMed ID: 19673089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical antipsychotics and neuroleptic malignant syndrome.
    Velamoor VR
    Can J Psychiatry; 2001 Nov; 46(9):865-6. PubMed ID: 11761644
    [No Abstract]   [Full Text] [Related]  

  • 11. Zuclopenthixol dihydrochloride for schizophrenia.
    Kumar A; Strech D
    Schizophr Bull; 2009 Sep; 35(5):855-6. PubMed ID: 19661197
    [No Abstract]   [Full Text] [Related]  

  • 12. Withdrawal-emergent respiratory dyskinesia with risperidone treated with clozapine.
    Mendhekar DN; Inamdar A
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):E24. PubMed ID: 20463136
    [No Abstract]   [Full Text] [Related]  

  • 13. Risperidone and tardive dyskinesia: a case of blepharospasm.
    Mullen A
    Aust N Z J Psychiatry; 2000 Oct; 34(5):879-80. PubMed ID: 11037386
    [No Abstract]   [Full Text] [Related]  

  • 14. Cocaine and catatonia.
    Gingrich JA; Rudnick-Levin F; Almeida C; Innes L; Schneier H
    Am J Psychiatry; 1998 Nov; 155(11):1629. PubMed ID: 9812136
    [No Abstract]   [Full Text] [Related]  

  • 15. Catatonia, neuroleptics and brain damage--a case report.
    Chandran M; El-Shazly M
    J Psychopharmacol; 2009 Mar; 23(2):223-6. PubMed ID: 18562406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case report of neuroleptic malignant syndrome with prolonged mental changes and severe dyskinesia.
    Chung YJ; Lee SJ
    Asia Pac Psychiatry; 2018 Mar; 10(1):. PubMed ID: 29464897
    [No Abstract]   [Full Text] [Related]  

  • 17. [Catatonia, malignant neuroleptic syndrome and myositis ossificans].
    Topka H; Buchkremer G
    Nervenarzt; 1996 May; 67(5):413-7. PubMed ID: 9005354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catatonia in psychiatric classification.
    Van Den Eede F; Sabbe B
    Am J Psychiatry; 2004 Dec; 161(12):2327-8; author reply 2328. PubMed ID: 15569914
    [No Abstract]   [Full Text] [Related]  

  • 19. Movement disorders with neuroleptic drug treatment.
    Tarsy D
    Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical neuroleptic malignant syndrome associated with iloperidone administration.
    Guanci N; Aggarwal R; Schleifer S
    Psychosomatics; 2012; 53(6):603-5. PubMed ID: 23157999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.